Adverse systemic reaction to benznidazole.
Mostra el registre complet de l'element
|
Visualització
 (1.108Mb)
|
|
|
|
|
|
|
Pacheco Coronel, Maria Verónica; Oriente Frutos, Laura; Calabuig Muñoz, Eva; Kury Valle, Diana; Hernández Fernández de Rojas, Dolores
|
|
Aquest document és un/a article, creat/da en: 2017
|
|
|
|
Benznidazole, drug of choice for Chagas disease (CD), has been associated with a high incidence of adverse reactions that can become serious, necessitating discontinuation of the drug. We describe the case of a Bolivian patient living in Spain for 9 years, who, following treatment with benznidazole for CD in indeterminate chronic phase, presented with fever, skin lesions, digestive symptoms, general malaise, and laboratory abnormalities. After the discontinuation of benznidazole and, the intake of antihistamines and systemic corticosteroids, the patient presented a complete resolution of the symptoms. Optimization of dose strategies and development of more effective, and better-tolerated drugs is advisable. |
|
|
Veure al catàleg Trobes
|
Aquest element apareix en la col·lecció o col·leccions següent(s)
Mostra el registre complet de l'element
